01. Gene therapy Boulikas.pdf - Gene therapy & Molecular Biology

Schild L (1996) The ENaC channel as the primary determinant
of two human diseases: Liddle syndrome and
pseudohypoaldosteronism. Nephrologie 17, 395-400.
Schlake T, Klehr-Wirth D, Yoshida M, Beppu T, and Bode J
(1994) Gene expression within a chromatin domain: the role
of core histone hyperacetylation. Biochemistry 33, 4197-
4206.
Schwartz B, Benoist C, Abdallah B, Rangara R, Hassan A,
Scherman D, Demeneix BA (1996) Gene transfer by naked
DNA into adult mouse brain. Gene Ther 3, 405-411.
Schwartz B, Benoist C, Abdallah B, Scherman D, Behr J-P, and
Demeneix BA (1995) Lipospermine-based gene transfer into
the newborn mouse brain is optimized by a low
lipospermine/DNA charge ratio. Hum Gene Ther 6, 1515-
1524.
Schwarzenberger P, Spence SE, Gooya JM, Michiel D, Curiel
DT, Ruscetti FW, Keller JR (1996) Targeted gene transfer to
human hematopoietic progenitor cell lines through the c-kit
receptor. Blood 87, 472-478.
Seibel P, Trappe J, Villani G, Klopstock T, Papa S, and
Reichman H: Transfection of mitochondria: strategy towards
a gene therapy of mitochondrial DNA diseases. Nucleic
Acids Res 23: 10-17, 1995.
Senger DR, van de Water L, Brown LF, Nagy JA, Yeo K-T, Yeo
T-K, Berse B, Jackman RW, Dvorak AM, and Dvorak HF
(1993) Vascular permeability factor (VPF, VEGF) in tumor
biology. Cancer Metastasis Rev 12, 303-324.
Serio D, Rizvi TA, Cartas M, Kalyanaraman VS, Weber IT,
Koprowski H, Srinivasan A (1997) Development of a novel
anti-HIV-1 agent from within: effect of chimeric Vprcontaining
protease cleavage site residues on virus
replication. Proc Natl Acad Sci USA 94, 3346-3351.
Seth P (1994) Adenovirus-dependent release of choline from
plasma membrane vesicles at an acidic pH is mediated by the
penton base protein. J Virol 68, 1204-1206.
Seth P, FitzGerald D, Ginsberg H, Willingham M and Pastan I
(1984) Evidence that the penton base of adenovirus is
involved in potentiation of toxicity of Pseudomonas exotoxin
conjugated to epidermal growth factor. Mol Cell Biol 4,
1528-1533.
Seto E, Usheva A, Zambetti GP, Momand J, Horikoshi N,
Weinmann R, Levine AJ, Shenk T (1992) Wild-type p53
binds to the TATA-binding protein and represses
transcription. Proc Natl Acad Sci USA 89, 12028-12032.
Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu X,
Breitman ML, and Schuh AC (1995) Failure of blood island
formation and vasculogenesis in Flk-1-defficient mice.
Nature 376, 62-66.
Shan B and Lee WH (1994) Deregulated expression of E2F-1
induces S-phase entry and leads to apoptosis. Mol Cell Biol
14, 8166-8173.
Shan B, Chang CY, Jones D, Lee WH (1994) The transcription
factor E2F-1 mediates the autoregulation of RB gene
expression. Mol Cell Biol 14, 299-309.
Shan B, Zhu X, Chen PL, Durfee T, Yang Y, Sharp D, Lee WH
(1992) Molecular cloning of cellular genes encoding
retinoblastoma-associated proteins: identification of a gene
Boulikas: An overview on gene therapy
156
with properties of the transcription factor E2F. Mol. Cell.
Biol. 12, 5620-5631.
Sharma S, Cantwell M, Kipps TJ, Friedmann T (1996) Efficient
infection of a human T-cell line and of human primary
peripheral blood leukocytes with a pseudotyped retrovirus
vector. Proc Natl Acad Sci USA 93, 11842-11847.
Shen F, Ross JF, Wang X, and Ratnam M (1994) Identification
of a novel folate receptor, a truncated receptor, and receptor
type b in hematopoietic cells: cDNA cloning, expression,
immunoreactivity, and tissue specificity. Biochemistry 33,
1209-1215.
Shen Y and Shenk T (1994) Relief of p53-mediated
transcriptional repression by the adenovirus E1B 19-kDa
protein or the cellular Bcl-2 protein. Proc Natl Acad Sci
USA 91, 8940-8944.
Shevelev A, Burfeind P, Schulze E, Rininsland F, Johnson TR,
Trojan J, Chernicky CL, Hélène C, Ilan J, Ilan J (1997)
Potential triple helix-mediated inhibition of IGF-I gene
expression significantly reduces tumorigenicity of
glioblastoma in an animal model. Cancer Gene Ther 4, 105-
112.
Shi CS and Kehrl JH (1997) Activation of stress-activated
protein Kinase/c-Jun N-terminal kinase, but not NF-κB, by
the tumor necrosis factor (TNF) receptor 1 through a TNF
receptor-associated factor 2- and germinal center kinase
related-dependent pathway. J Biol Chem 272, 32102-32107.
Shih CC, Stoye JP, Coffin JM (1988) Highly preferred targets for
retrovirus integration. Cell 53, 531-537.
Shiio Y, Sawada J, Handa H, Yamamoto T, Inoue J (1996)
Activation of the retinoblastoma gene expression by Bcl-3:
implication for muscle cell differentiation. Oncogene 12,
1837-1845.
Shiio Y, Yammoto T, Yamaguchi N (1992) Negative regulation
of Rb expression by the p53 gene product. Proc Natl Acad
Sci USA 89, 5206-5210.
Shimkets RA, Warnock DG, Bositis CM, Nelson-Williams C,
Hansson JH, Schambelan M, Gill JR Jr, Ulick S, Milora RV,
Findling JW, et al (1994) Liddle's syndrome: heritable
human hypertension caused by mutations in the β subunit of
the epithelial sodium channel. Cell 79, 407-414.
Shirodkar, S., Ewen, M., DeCaprio, J.A., Morgan, J., Livingston,
D.M. and Chittenden, T. (1992) The transcription factor E2F
interacts with the retinoblastoma product and a p107-cyclin
A complex in a cell cycle-regulated manner. Cell 68, 157-
166.
Shivakumar CV, Brown DR, Deb S, Deb SP (1995) Wild-type
human p53 transactivates the human proliferating cell
nuclear antigen promoter. Mol Cell Biol 15, 6785-6793.
Shweiki D, Itin A, Soffer D, and Keshet E (1992) Vascular
endothelial growth factor induced by hypoxia may mediate
hypoxia-initiated angiogenesis. Nature 359, 843-845.
Sime PJ, Xing Z, Graham FL, Csaky KG, Gauldie J (1997)
Adenovector-mediated gene transfer of active transforming
growth factor-β1 induces prolonged severe fibrosis in rat
lung. J Clin Invest 100, 768-776.
Simons M, Edelman ER, Rosenberg RD (1994) Antisense
proliferating cell nuclear antigen oligonucleotides inhibit